Lido Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,382
Closed -$1.11M 2008
2025
Q4
$1.11M Sell
12,382
-12,475
-50% -$1M ﹤0.01% 964
2025
Q3
$1.36M Buy
24,857
+953
+4% +$47.6K ﹤0.01% 816
2025
Q2
$1.27M Buy
23,904
+189
+0.8% +$9.6K ﹤0.01% 742
2025
Q1
$1.03M Sell
23,715
-397
-2% -$20.1K ﹤0.01% 769
2024
Q4
$1.35M Buy
24,112
+18,772
+352% +$1.17M 0.01% 643
2024
Q3
$364K Sell
5,340
-126
-2% -$7.11K ﹤0.01% 1082
2024
Q2
$231K Buy
5,466
+237
+5% +$13K ﹤0.01% 1232
2024
Q1
$361K Sell
5,229
-129
-2% -$8.16K ﹤0.01% 1006
2023
Q4
$396K Sell
5,358
-328
-6% -$21.5K ﹤0.01% 931
2023
Q3
$388K Buy
5,686
+240
+4% +$20.4K ﹤0.01% 833
2023
Q2
$511K Buy
5,446
+44
+0.8% +$3.43K ﹤0.01% 733
2023
Q1
$366K Sell
5,402
-1,120
-17% -$72K ﹤0.01% 806
2022
Q4
$323K Buy
+6,522
New +$266K ﹤0.01% 771
2022
Q3
Sell
-6,056
Closed -$238K 976
2022
Q2
$238K Buy
+6,056
New +$324K ﹤0.01% 814
2021
Q3
Sell
-1,709
Closed -$212K 981
2021
Q2
$212K Buy
+1,709
New +$204K ﹤0.01% 850

Other funds holding EXAS

Lido Advisors's EXAS Position: Q1 2026 in Review

Lido Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12,382 shares — an estimated $1.11M sold.

Lido Advisors first reported a position in EXAS in Q2 2021 and held it in 15 quarters. The position peaked at $1.36M in Q3 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Lido Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Lido Advisors sold 12,382 Exact Sciences shares in Q1 2026, an estimated $1.11M.
  • Lido Advisors first reported a position in Exact Sciences in Q2 2021 and held it in 15 quarters.
  • Lido Advisors's Exact Sciences position peaked at $1.36M in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.